| IGALMI Bioxcel Therapeutics, Inc.
90295383 03 Nov 2020 | on 12 Nov 2024
| Pharmaceuticals for the treatment of agitation, namely, an orally-diss... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with central nervous system disorders, namely, schizophrenia and bipolar disorder | | | Logo Mark Bioxcel Therapeutics, Inc.
90321408 16 Nov 2020 | on 03 Sep 2024
| Pharmaceuticals for the treatment of agitation; pharmaceuticals for th... Class 005 Class 005 Pharmaceutical Products The mark consists of stylized horizontal figure 8 design, with the left side blue and right side green and with lines extending from the center appearing in the colors white and navy blue. | | | BT Bioxcel Therapeutics, Inc.
88910081 11 May 2020 | on 16 Aug 2022
| Pharmaceutical preparations in the field of immuno-oncology; pharmaceu... Class 005 Class 005 Pharmaceutical Products The mark consists of stylized letters "b" and "t". Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions | | | BT BIOXCEL THERAPEUTICS Bioxcel Therapeutics, Inc.
88885185 23 Apr 2020 | on 25 May 2021
| Pharmaceutical preparations in the field of immuno-oncology; pharmaceu... Class 005 Class 005 Pharmaceutical Products "THERAPEUTICS" Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical preparations in the field of immuno-oncology; pharmaceutical preparations for the treatment of neurological conditions | | | IGALMI BioXcel Therapeutics, Inc.
98620766 26 Jun 2024 | on 27 Dec 2024 | Pharmaceuticals for the treatment of agitation, namely, an orally-diss... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of agitation, namely, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, namely, dementia and depression | | | KALMPEN Bioxcel Therapeutics, Inc.
88694201 15 Nov 2019 | on 08 Jan 2024 | Injectable pharmaceuticals for the treatment of agitation; injectable ... Class 005 Class 005 Pharmaceutical Products Injectable pharmaceuticals for the treatment of agitation; injectable pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal and other related central nervous system disorders | | | RELFINBI Bioxcel Therapeutics, Inc.
97021169 10 Sep 2021 | on 17 Apr 2023 | Pharmaceuticals for the treatment of central nervous system disorders;... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, schizophrenia, bipolar disorder, dementia, delirium, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or any other central nervous system disorder; pharmaceuticals for the treatment of symptoms associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or other central nervous system disorders | | | ZELTIGNA Bioxcel Therapeutics, Inc.
97021171 10 Sep 2021 | on 17 Apr 2023 | Pharmaceuticals for the treatment of central nervous system disorders;... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, schizophrenia, bipolar disorder, dementia, delirium, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or any other central nervous system disorder; pharmaceuticals for the treatment of symptoms associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or other central nervous system disorders | | | OMFILTO Bioxcel Therapeutics, Inc.
97021170 10 Sep 2021 | on 17 Apr 2023 | Pharmaceuticals for the treatment of central nervous system disorders;... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, schizophrenia, bipolar disorder, dementia, delirium, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or any other central nervous system disorder; pharmaceuticals for the treatment of symptoms associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or other central nervous system disorders | | | ALMIQI Bioxcel Therapeutics, Inc.
90295385 03 Nov 2020 | on 15 Aug 2022 | Pharmaceuticals for the treatment of agitation; pharmaceuticals for th... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders | | 
